Navigation Links
Scientists find key to growth of 'bad' bacteria in inflammatory bowel disease
Date:2/7/2013

(SACRAMENTO, Calif.) Scientists have long puzzled over why "bad" bacteria such as E. coli can thrive in the guts of those with inflammatory bowel disease (IBD), causing serious diarrhea. Now UC Davis researchers have discovered the answerone that may be the first step toward finding new and better treatments for IBD.

The researchers discovered a biological mechanism by which harmful bacteria grow, edge out beneficial bacteria and damage the gut in IBD. This new understanding, published in the Feb. 8 issue of Science, may help researchers develop new treatments for IBD with fewer side effects than current therapies.

IBD begins when "good" bacteria are mistakenly killed by the immune system, while harmful bacteria multiply resulting in inflammation and damage to the intestines, and chronic episodes of abdominal pain, cramping, diarrhea and other changes in bowel habits. It's estimated that IBD, which includes ulcerative colitis and Crohn's disease, affects 1.4 million people in the U.S., according to the Centers for Disease Control and Prevention.

In test-tube and animal studies, the researchers found that potentially harmful bacteria in the intestine called Enterobacteriaceae use nitrate a byproduct formed during the intestinal inflammation in IBD to grow and thrive. Enterobacteriaceae strains include certain E. coli bacteria, which can worsen the intestinal damage of IBD. Eventually, the intestines of those with IBD become overrun by harmful bacteria, and the numbers of normal good bacteria in the gut decrease.

"Much like humans use oxygen, E. coli can use nitrate as a replacement for oxygen to respire, produce energy and grow," said lead author Andreas Baumler, a professor of medical microbiology and immunology at UC Davis.

"In IBD, nitrate produced by inflammation in the gut allows E. coli to take a deep 'breath,' and beat out our beneficial microbes in the competition for nutrients," he said.

The inflammation in the intestines of those with IBD leads to the release of nitric oxide radicals that are powerful in attacking bacteria, Baumler explained. Yet these nitric oxide radicals are also very unstable, and eventually decompose into nitrate, which can be used by bacteria like E. coli to thrive and grow. By contrast, good bacteria in the gut grows through fermentation a much slower process.

Determining the reasons why bacteria like E. coli can edge out good bacteria in the gut is crucial for determining new ways to halt the IBD disease process, according to Baumler. Current treatments for IBD suppress the immune response through antibiotics, corticosteroids or other powerful immune-modifying drugs. But long-term side effects can limit their use and their effectiveness for IBD patients.

The UC Davis team's research indicates that targeting the molecular pathways that generate nitric oxide and nitrate, as well as other molecules that feed harmful gut bacteria, could calm down and normalize the intestinal environment in IBD, Baumler noted. They are already doing research with one candidate drug that could halt the multiple pathways by which harmful bacteria thrive in IBD.

"The idea would be to inhibit all pathways that produce molecules that can be used by bacteria such as E. coli for respiration and growth," Baumler said. "Essentially you could then smother the bacteria."


'/>"/>

Contact: Carole Gan
carole.gan@ucdmc.ucdavis.edu
916-734-9047
University of California - Davis Health System
Source:Eurekalert

Related medicine news :

1. Scientists Explore How Zinc Fights Off Infection
2. Compound developed by scientists protects heart cells during and after attack
3. Scientists discover how chromosomes keep their loose ends loose
4. Meeting: Scientists to explore 60 topical issues related to human health and the environment
5. Scientists debate CDC recommendations during meningitis outbreak
6. Scientists discover protein that allows safe recycling of iron from old red blood cells
7. MU scientists build harness for powerful radiation cancer therapy
8. Monell scientists identify elusive taste stem cells
9. American Association of Radon Scientists and Technologists (AARST) Releases Nation's First Standard for Mitigating Radon (Radioactivity) in Multifamily Buildings
10. Scientists Find Clue to Aging Reversal in Mice
11. Leading researchers warn of brain drain as scientists struggle to find funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... ... 20, 2017 , ... Researchers at the University of Pittsburgh School of Medicine ... that may predict response to a particular class of drugs, not just in patients ... The new findings were published in Proceedings of the National Academy of Science. , ...
(Date:2/20/2017)... ... 2017 , ... The StayWell Company and VUCA Health ... health risks, foster behavior change and improve health literacy among patients. VUCA Health, which ... demonstration of its video capability at StayWell booth 3443 during HiMSS. , The ...
(Date:2/20/2017)... ... February 20, 2017 , ... Sensogram Technologies Inc., the world ... visit this week at HIMSS 2017 Conference & Exhibition. The event brings more ... will be featured in the conference’s Connected Health Experience section, an area specifically ...
(Date:2/20/2017)... ... ... a Population Health Software Company, is pleased to announce a move to a larger office ... the size of the previous location while bringing life back to a medical practice building ... are excited to expand our footprint to better serve our growing client base. We ...
(Date:2/20/2017)... ... February 20, 2017 , ... Johns Hopkins All Children's Hospital ... A topping out ceremony on Friday marked the halfway point of construction and lifting ... in Fall 2018, will serve as a center for innovation aimed at finding new ...
Breaking Medicine News(10 mins):
(Date:2/20/2017)... Feb. 20, 2017  This report analyzes the worldwide markets ... Million. The report provides separate comprehensive analytics for the ... , Europe , ... and Rest of World. Read the ... and forecasts are provided for the period 2015 through ...
(Date:2/20/2017)... Feb. 20, 2017 Research and Markets has ... Insights, Opportunity, Analysis, Market Shares & Forecast 2017 - 2022" ... ... nearly USD 2 Billion by the year end of 2022 growing ... Market growth can be attributed to factors such as ...
(Date:2/20/2017)... -- Seal Shield LLC ( Jacksonville, FL ... management and disinfection, the ElectroClave™, to the exhibit floor ... Orlando, Fla. from February 20-23, 2017 ... commonplace in today,s healthcare landscape, but with this progression ... the disinfection and tracking of these devices.  The ElectroClave™ ...
Breaking Medicine Technology: